A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer

[1] Vanderwalde A(2018)Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients Cancer medicine 7 746-756

[2] Spetzler D(2016)The evolving role of microsatellite instability in colorectal cancer: a review Cancer Treat Rev 51 19-26

[3] Xiao N(2017)A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer BMC Cancer 17 844-3226

[4] Gatalica Z(2010)Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 3219-257

[5] Marshall J(2003)Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 247-595

[6] Gelsomino F(2012)A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency J Pathol 228 586-370

[7] Barbolini M(2018)Microsatellite instability in prostate cancer by PCR or next-generation sequencing J Immunother Cancer 6 29-958

[8] Spallanzani A(2014)Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012 Arch Path Lab Med 138 363-69

[9] Pugliese G(2018)Accurate Pan-Cancer molecular diagnosis of microsatellite instability by single-molecule molecular inversion probe capture and high-throughput sequencing Clin Chem 64 950-57

[10] Cascinu S(2016)Molecular diagnostics for precision medicine in colorectal Cancer: current status and future perspective Biomed Res Int 2016 9850690-154

[1] Vanderwalde A(2018)Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients Cancer medicine 7 746-756

[2] Spetzler D(2016)The evolving role of microsatellite instability in colorectal cancer: a review Cancer Treat Rev 51 19-26

[3] Xiao N(2017)A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer BMC Cancer 17 844-3226

[4] Gatalica Z(2010)Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer J Clin Oncol 28 3219-257

[5] Marshall J(2003)Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 247-595

[6] Gelsomino F(2012)A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency J Pathol 228 586-370

[7] Barbolini M(2018)Microsatellite instability in prostate cancer by PCR or next-generation sequencing J Immunother Cancer 6 29-958

[8] Spallanzani A(2014)Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012 Arch Path Lab Med 138 363-69

[9] Pugliese G(2018)Accurate Pan-Cancer molecular diagnosis of microsatellite instability by single-molecule molecular inversion probe capture and high-throughput sequencing Clin Chem 64 950-57

[10] Cascinu S(2016)Molecular diagnostics for precision medicine in colorectal Cancer: current status and future perspective Biomed Res Int 2016 9850690-154